Tag: Recro Pharma

Finance

Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Facebook Inc. (NASDAQ:FB), which closed its acquisition of mobile messaging service WhatsApp on Monday, has no near-term plan to make money from the service, Chief Executive Mark Zuckerberg said on Thursday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -5.85%. On last trading day company shares ended up $72.91. Facebook Inc (NASDAQ:FB) distance from 50-day simple … Continue reading Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Jayne Crisman
Finance

Today’s Watch List : Nabors Industries (NYSE:NBR), Wells Fargo & Company (NYSE:WFC), Progenics Pharmaceuticals (NASDAQ:PGNX), Recro Pharma (NASDAQ:REPH), Masco Corporation (NYSE:MAS),

Nabors Industries (NYSE:NBR) has been given a “BBB-” credit rating by Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Nabors Industries Ltd. (NYSE:NBR) belongs to Basic Materials sector. Its net profit margin is 2.40% and weekly performance is 0.12%. … Continue reading Today’s Watch List : Nabors Industries (NYSE:NBR), Wells Fargo & Company (NYSE:WFC), Progenics Pharmaceuticals (NASDAQ:PGNX), Recro Pharma (NASDAQ:REPH), Masco Corporation (NYSE:MAS),

Colin Pettis
Finance

Whats Hot Today: Verizon Communications Inc. (NYSE:VZ), Recro Pharma, Inc. (NASDAQ:REPH), Symantec Corporation (NASDAQ:SYMC), USEC Inc. (NYSE:USU), Enbridge Inc. (NYSE:ENB)

CNBC’s Jon Fortt talked to Dan Mead, Verizon Wireless President & CEO in a program about Verizon Communications Inc. (NYSE:VZ)’s expectations from Apple Inc. (NASDAQ:AAPL) and future business plans. Mead said that Apple Inc. (NASDAQ:AAPL) is a very important business partner of Verizon in the industry and he is extremely excited about the product launch event of Apple Inc. (NASDAQ:AAPL) today.Verizon Communications Inc. (NYSE:VZ) belongs … Continue reading Whats Hot Today: Verizon Communications Inc. (NYSE:VZ), Recro Pharma, Inc. (NASDAQ:REPH), Symantec Corporation (NASDAQ:SYMC), USEC Inc. (NYSE:USU), Enbridge Inc. (NYSE:ENB)

Ryan Holtz
Finance

Healthcare Watch list: Biocept Inc (NASDAQ:BIOC), Recro Pharma Inc (NASDAQ:REPH), Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Trevena Inc (NASDAQ:TRVN)

Biocept Inc (NASDAQ:BIOC) has appointed Raaj Trivedi as vice president of commercial operations. Biocept Inc (NASDAQ:BIOC) stock performance was -9.62% in last session and finished the day at $6.39. Traded volume was 24,173.00million shares in the last session and the average volume of the stock remained 47.03K shares. Biocept Inc (NASDAQ:BIOC) insider ownership is 0.40%. On March 12, 2014, Recro Pharma, Inc. (NASDAQ:REPH) completed its … Continue reading Healthcare Watch list: Biocept Inc (NASDAQ:BIOC), Recro Pharma Inc (NASDAQ:REPH), Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Trevena Inc (NASDAQ:TRVN)

Colin Pettis
Finance

Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded volume was 43.6K shares in the last session and the … Continue reading Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Chris Lewis
Finance

Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Recro Pharma, Inc. (NASDAQ:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today announced the appointments of Alfred F. Altomari and Dr. Michael Berelowitz to the Company’s Board of Directors. Recro Pharma Inc (NASDAQ:REPH) stock performance was 1.95% in last session and finished the day at $7.32. Traded volume was 35,553.00million shares in the last session and the average volume of … Continue reading Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Jason Knox